Science Explorer Back to mapMap
Discussion
Researcher · Evotec (Germany) · Germany

Monika Ermann

Monika Ermann publishes mostly in Molecular Biology, Organic Chemistry and Pharmacology, on topics such as Chemical Synthesis and Analysis, Cannabis and Cannabinoid Research and Synthesis and Biological Evaluation.

ORCID 0000-0003-1030-721X OpenAlex
World rank
#5,493,695
of 7,710,434 ranked researchers
Rank in Germany
#283,706
of 364,343
Works
18
Citations
420
Citations per work
23.3
h-index
11
i10-index 12Top 71% in Molecular Biology
Monika Ermann

What does Monika Ermann research?

Monika Ermann's work is mostly in Biochemistry, Genetics and Molecular Biology (40%), Chemistry (25%), Medicine (10%).

Life Sciences: 10 works · 55.7% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 40.3% of their workMolecular Biology: 7 works · 36.5% of their workPhysiology: 1 works · 3.8% of their workImmunology and Microbiology: 1 works · 7.7% of their workImmunology: 1 works · 7.7% of their workNeuroscience: 1 works · 7.7% of their workCellular and Molecular Neuroscience: 1 works · 7.7% of their workPhysical Sciences: 4 works · 25.0% of their workChemistry: 4 works · 25.0% of their workOrganic Chemistry: 4 works · 25.0% of their workEverything else: 2 works · 9.7% of their workHealth Sciences: 2 works · 9.6% of their workMedicine: 2 works · 9.6% of their workPharmacology: 2 works · 9.6% of their workTHEIR WORKMonika Ermann18works
Life Sciences56%Physical Sciences25%Health Sciences10%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology740.3%
    2. Immunology and Microbiology17.7%
    3. Neuroscience17.7%
    1. Chemistry425.0%
  3. Everything else29.7%
    1. Medicine29.6%
  1. 1Molecular Biology36% of their works
  2. 2Organic Chemistry25% of their works
  3. 3Pharmacology10% of their works
  4. 4Immunology8% of their works
  5. 5Cellular and Molecular Neuroscience8% of their works
  6. 6Physiology4% of their works

Research topics

Which keywords describe Monika Ermann's research?

The keywords of their largest research topics: Drug Discovery, Neuroprotection, Cannabinoid Receptors, Endocannabinoid System, Foldamers, Peptide Synthesis, Quinoxaline and Synthesis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Drug Discovery82 topics
  2. Neuroprotection82 topics
  3. Cannabinoid Receptors51 topic
  4. Endocannabinoid System51 topic
  5. Foldamers51 topic
  6. Peptide Synthesis51 topic
  7. Quinoxaline41 topic
  8. Synthesis41 topic
  9. Chaperone31 topic
  10. Cyclic Nucleotide Phosphodiesterases31 topic
  11. Dopamine31 topic
  12. Green Chemistry31 topic
  13. Multicomponent Reactions31 topic
  14. Serotonin31 topic
  15. Sigma-1 Receptor31 topic
  16. cAMP Signaling31 topic
  17. Enzyme Regulation21 topic
  18. Nucleotide Metabolism21 topic

Where does Monika Ermann work?

Monika Ermann's main affiliation in the publication record is Evotec (Germany), Germany.

How many publications and citations does Monika Ermann have?

OpenAlex counts 18 works and 420 citations for Monika Ermann, an h-index of 11, ranking #5,493,695 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Monika Ermann. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.